Joseph J. Elliot
Geen lopende functies
Profiel
Joseph J.
Elliot formerly worked at LymphoSign, Inc., as President & Chief Executive Officer, Receptor Therapeutics, Inc., as President, Chief Executive Officer & Director, Cytochroma, Inc., as Chairman & President, Targanta Therapeutics, Inc., as Chairman & President, Nexia Biotechnologies, Inc., as Director, BioStar, Inc., as Director, MDS Proteomics, Inc., as Vice President & General Manager, Lumira Capital Investment Management, Inc., as Vice President in 1999, Pharmacia Canada, Inc., as Principal, Exogen Neurosciences, Inc., as Chief Operating Officer, MDS Ocata, Inc., as Vice President & General Manager-Operations in 2012, and Sanofi-Aventis Canada, Inc., as Principal.
Dr. Elliot received his doctorate degree in 1980 from McMaster University.
Eerdere bekende functies van Joseph J. Elliot
| Bedrijven | Functie | Einde |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Corporate Officer/Principal | 01-01-1999 |
Sanofi-Aventis Canada, Inc.
 Sanofi-Aventis Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi-aventis Canada Inc. is the Canadian affiliate of the sanofi-aventis Group, one of the world's leading pharmaceutical companies. They are headquartered in Laval, Quebec, and employ 900 people across the country. Their Laval site is also home to a world-class manufacturing facility that produces medications for use by patients in Canada, the United States and other countries. As a leading healthcare partner they provide, and are developing, innovative medicines for treatments in several therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic disorders, the central nervous system, and internal medicine. They also play a role by investing in activities that improve health and quality of life in their communities. The sanofi-aventis Group is also represented in Canada by Sanofi Pasteur Limited. Located in Toronto, the company is Canada's largest producer of vaccines and employs 1,200 people. | Corporate Officer/Principal | - |
| Pharmacia Canada, Inc. | Corporate Officer/Principal | - |
| MDS Ocata, Inc. | Operationeel Directeur | - |
| Exogen Neurosciences, Inc. | Operationeel Directeur | - |
Opleiding van Joseph J. Elliot
| McMaster University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Health Technology |
Receptor Therapeutics, Inc.
 Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Health Technology |
| MDS Proteomics, Inc. | Commercial Services |
Targanta Therapeutics, Inc.
 Targanta Therapeutics, Inc. BiotechnologyHealth Technology Targanta Therapeutics, Inc. develops antibiotic drugs and other related products. It focuses on developing and commercializing novel antibacterial agents to address unmet medical needs in the hospital market. The company also develops antibacterial pro-drugs for the treatment and prevention of bone infections. Targanta Therapeutics was founded in May 2007 and is located in St. Laurent, Canada | Health Technology |
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
Nexia Biotechnologies, Inc.
 Nexia Biotechnologies, Inc. BiotechnologyHealth Technology Nexia Biotechnologies produces therapeutic proteins and other biomaterials for the treatment of serious disease | Health Technology |
| BioStar, Inc. | Health Technology |
| MDS Ocata, Inc. | |
| Exogen Neurosciences, Inc. | |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
| Pharmacia Canada, Inc. | |
Sanofi-Aventis Canada, Inc.
Sanofi-Aventis Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi-aventis Canada Inc. is the Canadian affiliate of the sanofi-aventis Group, one of the world's leading pharmaceutical companies. They are headquartered in Laval, Quebec, and employ 900 people across the country. Their Laval site is also home to a world-class manufacturing facility that produces medications for use by patients in Canada, the United States and other countries. As a leading healthcare partner they provide, and are developing, innovative medicines for treatments in several therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic disorders, the central nervous system, and internal medicine. They also play a role by investing in activities that improve health and quality of life in their communities. The sanofi-aventis Group is also represented in Canada by Sanofi Pasteur Limited. Located in Toronto, the company is Canada's largest producer of vaccines and employs 1,200 people. | Health Technology |
